bioRxivCancer BiologyPreprint
Physical Activity Delays Obesity-Associated Pancreatic Ductal Adenocarcinoma in Mice and Decreases Inflammation
V. Pita-Grisanti, K. Dubay, A. Lahooti, N. Badi, O. Ueltschi, K. Gumpper-Fedus, H.-Y. Hsueh, I. Lahooti, M. Chavez-Tomar, S. Terhorst, S. E. Knoblaugh, L. Cao, W. Huang, C. C. Coss, T. Mace, F. Choueiry, A. Hinton, J. M. Mitchell, R. Schmandt, M. Onstad Grinsfelder, K. Basen-Engquist, Z. Cruz-Monserrate
Abstract
BACKGROUND & AIMSObesity is a risk factor for pancreatic ductal adenocarcinoma (PDAC), a deadly disease with limited preventive strategies. Lifestyle interventions to decrease obesity might prevent obesity-associated PDAC. Here, we examined whether decreasing obesity by increased physical activity (PA) and/or dietary changes would decrease inflammation in humans and prevent PDAC in mice. METHODSCirculating inflammatory-associated cytokines of overweight and obese subjects before and after a PA intervention were compared. PDAC pre-clinical models were exposed to PA and/or dietary interventions after obesity-associated cancer initiation. Body composition, tumor progression, growth, fibrosis, inflammation, and transcriptomic changes in the adipose tissue were evaluated. RESULTSPA decreased the levels of systemic inflammatory cytokines in overweight and obese subjects. PDAC mice on a diet-induced obesity (DIO) and PA intervention, had delayed weight gain, decreased systemic inflammation, lower grade pancreatic intraepithelial neoplasia lesions, reduced PDAC incidence, and increased anti-inflammatory signals in the adipose tissue compared to controls. PA had additional cancer prevention benefits when combined with a non-obesogenic diet after DIO. However, weight loss through PA alone or combined with a dietary intervention did not prevent tumor growth in an orthotopic PDAC model. Adipose-specific targeting of interleukin (IL)-15, an anti-inflammatory cytokine induced by PA in the adipose tissue, slowed PDAC growth. CONCLUSIONSPA alone or combined with diet-induced weight loss delayed the progression of PDAC and reduced systemic and adipose inflammatory signals. Therefore, obesity management via dietary interventions and/or PA, or modulating weight loss related pathways could prevent obesity-associated PDAC in high-risk obese individuals. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=69 SRC="FIGDIR/small/521203v1_ufig1.gif" ALT="Figure 1"> View larger version (28K): org.highwire.dtl.DTLVardef@961f1org.highwire.dtl.DTLVardef@1fd4da7org.highwire.dtl.DTLVardef@f5247aorg.highwire.dtl.DTLVardef@2de0bf_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: mouse
- assay: proteomics
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Endocrine-exocrine signaling drives obesity-associated pancreatic ductal adenocarcinoma
K. M. Chung, J. Singh, … M. D. Muzumdar·bioRxiv·Sep 26, 2019
- Ketogenic diet prevents obesity-associated pancreatic cancer independent of weight loss and induces pancreatic metabolic reprogramming
Ericka Vélez-Bonet, Kristyn Gumpper, … Zobeida Cruz‐Monserrate·Cancer ResearchPeer-reviewed·May 18, 2026
- Ppard Is Essential in Acceleration of Pancreatic Ductal Adenocarcinoma Development by High-Fat Diet in Mutant Kras Mice
Y. Liu, Y. Deguchi, … I. Shureiqi·bioRxiv·Dec 4, 2020
- Endogenous insulin contributes to pancreatic cancer development
A. M. Zhang, J. Magrill, … J. D. Johnson·bioRxiv·Jan 24, 2019
- Endogenous insulin mediates dynamic coordination between pancreatic cancer and systemic metabolism
Jeffrey S.H. Lin, Aman A Mohammed, … Janel L. Kopp·bioRxiv·Aug 27, 2026
- High-fat diet imprints a macrophage-tumor CAMP-P2RX7 axis driving pancreatic cancer initiation, plasticity and metastasis
Ana Galván-del-Rey, Juan Carlos López-Gil, … Carmen Guerra·bioRxiv·Feb 14, 2026